ArticleNPJ digital medicine2025
Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson's disease.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical utility and methodological implementation of smartphone-based mobility analysis: a scoping review.Journal of neurology · 2026Article
- Article
- Identifying and predicting fast versus slow Parkinson's disease motor progressors using clinical and digital data.BMJ neurology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dopamine transporter (DaT) SPECT can confirm dopaminergic deficiency in Parkinson's disease (PD) but remains costly and inaccessible. We investigated whether brief smartphone-based motor assessments could predict DaT scan results as a scalable alternative. Data from Oxford and Genoa cohorts included individuals with iRBD, PD, and controls. Machine learning models trained on smartphone-derived features classified DaT scan status and predicted striatal binding ratios, compared with MDS-UPDRS-III benchmarks. Among 100 DaT scans, the smartphone-only XGBoost model achieved AUC = 0.80, improving to 0.82 when combined with MDS-UPDRS-III (AUC's gender-corrected). A simpler logistic regression model performed better with MDS-UPDRS-III alone (AUC = 0.83) versus smartphone features, with slightly higher performance when combined (AUC = 0.85). Regression models predicted binding ratios with modest error (RMSE = 0.49, R² = 0.56). Gait, tremor, and dexterity features were most predictive. These findings support smartphone-based assessments complementing clinical evaluations, though larger independent validation remains essential.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.